CN101361870B - Traditional Chinese medicine combination for preventing infection after mouth operation - Google Patents

Traditional Chinese medicine combination for preventing infection after mouth operation Download PDF

Info

Publication number
CN101361870B
CN101361870B CN2008101678079A CN200810167807A CN101361870B CN 101361870 B CN101361870 B CN 101361870B CN 2008101678079 A CN2008101678079 A CN 2008101678079A CN 200810167807 A CN200810167807 A CN 200810167807A CN 101361870 B CN101361870 B CN 101361870B
Authority
CN
China
Prior art keywords
portions
parts
chinese medicine
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101678079A
Other languages
Chinese (zh)
Other versions
CN101361870A (en
Inventor
祝亮环
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101678079A priority Critical patent/CN101361870B/en
Publication of CN101361870A publication Critical patent/CN101361870A/en
Application granted granted Critical
Publication of CN101361870B publication Critical patent/CN101361870B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine combination which is used for preventing the infection after oral surgery and prepared by the following raw materials according to the following weight portion: 4 portions to 12 portions of earthworm, 5 portions to 15 portions of notoginseng, 3 portions to 15 portions of radix bupleuri, 3 portions to 15 portions of Sophora flavescens, 4 portions to 12 portions of semen cuscutae, 6 portions to 9 portions of rhizoma pinelliae, 1 portion to 5 portions of nutgall, 8 portions to 10 portions of safflower, 7 portions to 10 portions of Chinese goldthread and 7 portions to 9 portions of radix clematidis. The traditional Chinese medicine combination has good treatment effect on the symptoms of nausea and the prevention of wound infection after oral surgery, no postoperative complications occur to most patients taking the medicine, and the clinical treatment effect is accurate and reliable.

Description

A kind of Chinese medicine composition that is used to prevent infection after mouth operation
Technical field
The present invention relates to field of medicaments, specifically, the present invention relates to a kind of Chinese medicine composition that is used to prevent infection after mouth operation.
Background technology
The infection of wound takes place after the oral surgery easily.Many clinically at present is preventive means to take the Western medicine with antiinflammation.But oral surgery is generally all used anaesthetic, anaesthetic effect hour after operation, and the patient often has symptoms such as nauseating.This situation is not simply to use Western medicine just soluble.Therefore need clinically a kind of not only can prevention infection but also can eliminate the medicine of some ill symptomses of operation back.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that is used to prevent infection after mouth operation.
In order to realize purpose of the present invention, the invention provides a kind of Chinese medicine composition that is used to prevent infection after mouth operation, it is the medicament of being made according to weight portion by following bulk drugs: 7~9 parts of 4~12 parts of Pheretimas, 5~15 parts of Radix Notoginseng, 3~15 parts of Radix Bupleuri, 3~15 parts of Radix Sophorae Flavescentiss, 4~12 parts of Semen Cuscutae, 6~9 parts of the Rhizoma Pinelliaes, 1~5 part of Galla Chinensis, 8~10 parts on Flos Carthami, 7~10 parts of Rhizoma Coptidis and Radix Clematidis.
Preferably, Chinese medicine composition of the present invention by weight the proportioning of each crude drug be: 8 parts of 8 parts of Pheretimas, 10 parts of Radix Notoginseng, 7 parts of Radix Bupleuri, 7 parts of Radix Sophorae Flavescentiss, 8 parts of Semen Cuscutae, 7 parts of the Rhizoma Pinelliaes, 3 parts of Galla Chinensiss, 9 parts on Flos Carthami, 8 parts of Rhizoma Coptidis and Radix Clematidis.
Described pharmacy optimization is tablet, capsule, oral liquid, decoction or plaster.
Chinese medicine has stronger organic conception.Often can be treated, and just be not confined to focus itself from the characteristics of patient's whole body.For the patient behind the operation on oral cavity, except wanting prevent wound infection, also need to eliminate various post-operative complication, for example feel sick etc.These effects all are that Western medicine is beyond one's reach.And after taking Chinese medicine composition of the present invention, not only do not see postoperative wound infection, and patient's sensation such as more obviously be not sick in the stomach, clinical efficacy is definite.
The specific embodiment
Following examples are used to illustrate the present invention, but are not used for limiting the scope of the invention.
Embodiment 1
Get Pheretima 80 grams, Radix Notoginseng 100 grams, Radix Bupleuri 70 grams, Radix Sophorae Flavescentis 70 grams, Semen Cuscutae 80 grams, the Rhizoma Pinelliae 70 grams, Galla Chinensis 30 grams, Flos Carthami 90 grams, Rhizoma Coptidis 80 grams and Radix Clematidis 80 grams, add 1 premium on currency and refluxed 3 hours, filter, filtering residue added 2 premium on currency reflux 2 hours, filtered, and merged twice filtrate, it is 1.20 (60 ℃) that heating is concentrated into density, drying is pulverized, and adds microcrystalline Cellulose 300 grams, Icing Sugar 150 grams, granulate, incapsulate, promptly get 1000 of hard capsules.
Experimental example
1, clinical data
Patient's 20 examples after the oral surgery, male 11 examples, women 9 examples: 25 years old~65 years old age.All patients are all through surgical operation, the postoperative wound suture, and wound length is all less than 5 centimetres.
2, Therapeutic Method
2.1, medicine
Prepare capsule according to embodiment 1 described method, be used for this experimental example.
2.2, using method
Three times on the one, one time 5.Art was taken in preceding 3 hours.Took for 1 week continuously.
3, therapeutic outcome
Do not see that to see lump, flicking wound in the postoperative oral cavity it is standard that the swelling sense is not arranged in obvious pain, the oral cavity.By taking Chinese medicine composition of the present invention, find that whole patients all satisfy above-mentioned standard.And the investigation to them learns, patient's postoperative is perception sensation such as significantly feel sick not.
External fungistatic effect test
Strain: staphylococcus aureus, ATCC25923 is available from Nat'l Pharmaceutical ﹠ Biological Products Control Institute.Culture medium: M11 agar.Method: agar dilution.Test solution: get a capsule among the embodiment 1, content is all pulverized, add 1 ml water/1g content, ultrasonic dissolution, 0.8 micron filtering with microporous membrane, filtrate is according to the 1:2 two-fold dilution.Record minimum inhibitory concentration≤1:160, show that external fungistatic effect is good.

Claims (2)

1. Chinese medicine composition that is used to prevent infection after mouth operation is characterized in that it is the medicament of being made according to weight portion by following bulk drugs: 7~9 parts of 4~12 parts of Pheretimas, 5~15 parts of Radix Notoginseng, 3~15 parts of Radix Bupleuri, 3~15 parts of Radix Sophorae Flavescentiss, 4~12 parts of Semen Cuscutae, 6~9 parts of the Rhizoma Pinelliaes, 1~5 part of Galla Chinensis, 8~10 parts on Flos Carthami, 7~10 parts of Rhizoma Coptidis and Radix Clematidis.
2. Chinese medicine composition according to claim 1 is characterized in that the proportioning of each crude drug is by weight: 8 parts of 8 parts of Pheretimas, 10 parts of Radix Notoginseng, 7 parts of Radix Bupleuri, 7 parts of Radix Sophorae Flavescentiss, 8 parts of Semen Cuscutae, 7 parts of the Rhizoma Pinelliaes, 3 parts of Galla Chinensiss, 9 parts on Flos Carthami, 8 parts of Rhizoma Coptidis and Radix Clematidis.
CN2008101678079A 2008-10-13 2008-10-13 Traditional Chinese medicine combination for preventing infection after mouth operation Expired - Fee Related CN101361870B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101678079A CN101361870B (en) 2008-10-13 2008-10-13 Traditional Chinese medicine combination for preventing infection after mouth operation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101678079A CN101361870B (en) 2008-10-13 2008-10-13 Traditional Chinese medicine combination for preventing infection after mouth operation

Publications (2)

Publication Number Publication Date
CN101361870A CN101361870A (en) 2009-02-11
CN101361870B true CN101361870B (en) 2010-08-18

Family

ID=40388598

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101678079A Expired - Fee Related CN101361870B (en) 2008-10-13 2008-10-13 Traditional Chinese medicine combination for preventing infection after mouth operation

Country Status (1)

Country Link
CN (1) CN101361870B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579664B (en) * 2012-03-05 2014-03-05 济南伟传信息技术有限公司 Traditional Chinese medicine for quick healing of postoperative incision
CN102579807B (en) * 2012-03-21 2013-05-29 崔景明 Chinese medicine composition for treating dental ulcer
CN114129644A (en) * 2021-11-12 2022-03-04 山东睿鹰制药集团有限公司 A pharmaceutical composition for treating coronavirus infection, and its preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101264242A (en) * 2008-05-06 2008-09-17 中国中医科学院广安门医院 Medicaments preparations for treating hemorrhage, pain and dropsy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101264242A (en) * 2008-05-06 2008-09-17 中国中医科学院广安门医院 Medicaments preparations for treating hemorrhage, pain and dropsy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈约翰,等.中药"拔牙护创液"的临床应用初步观察.《上海中医药杂志》.1966,(第5期),194-195. *

Also Published As

Publication number Publication date
CN101361870A (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CN101361870B (en) Traditional Chinese medicine combination for preventing infection after mouth operation
CN102091134B (en) Traditional Chinese medicinal composition for resisting multi-medicine tolerance of antibiotics
CN102389528B (en) Traditional Chinese medicine used after operation for promoting wound healing
CN102258726A (en) Traditional Chinese medicine composition for treating tuberculosis
CN100594911C (en) Medicine composition and use
CN104740112A (en) Application of composition of lycopene and grape seed in preparation of drug used for treating arthritis
CN104758686A (en) Traditional Chinese medicine preparation for treating poor sleep quality
CN102240310A (en) Blood-sugar-reducing composition and preparation method thereof
CN103432506B (en) Pharmaceutical composition for treating upper respiratory infection
CN101804119B (en) Traditional Chinese medicine preparation for treating thrombocytopenia and preparation method thereof
CN101274031A (en) Medicament composition for curing irritable bowel syndrome
CN103520396B (en) Mouthwash used for preventing infection after oral implant rehabilitation
CN104013901A (en) Medicament for treating pelvic inflammation
US11911431B2 (en) Sustained release ashwagandha extract
CN103550372B (en) Medicament for medical abortion
CN115554345B (en) A Chinese medicinal compound preparation for treating gout and hyperuricemia, and its preparation method
CN102512652B (en) Medicinal composition for treating peptic ulcer
CN101249236A (en) Chinese and western medicinalcombine preparations for curing epileptic
CN103550373B (en) Medicament for treating gingivitis
CN101773620A (en) Heat-clearing stranguria-treating drug
CN101152389A (en) Traditional Chinese medicine for treating cestodiasis
CN104042950A (en) Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof
CN104666677A (en) Medicinal composition granule having functions of lowering blood sugar and preparation method thereof
CN103263425B (en) Fosfomycin trometamol is preparing the application in treating chronic bacterial prostatitis medicine
CN1923265B (en) Application of wheat germ oil in pharmaceutical preparation for preventing and treating osteoporosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100818

Termination date: 20111013